Raloxifene is the generic name for an osteoporosis medicine with the brand name Evista®, a product of Eli Lilly and Company. No generic version of Evista is available. The patent for Evista is valid until March of 2014; however, other circumstances, such as lawsuits, could delay this. Refer to Evista entry for information about this medicine.
Other Resources: